Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Merck KGaA
News
Earnings Growth Proves Drugmaker Made Right Moves
Yahoo/AP
earnings
Merck KGaA
Mylan
Novartis
Sandoz
Teva Pharmaceuticals
»
7 comments
News
Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS
Bloomberg
Merck KGaA
MS
multiple sclerosis
Novartis
»
112 comments
News
Merck KGaA Sticks to Pharmaceuticals Strategy, Handelsblatt Says
Bloomberg
Merck KGaA
»
Login
or
register
to post comments
News
Can Novartis Win Race to Launch First Oral Drug for MS?
BNET Pharma
Merck KGaA
MS
multiple sclerosis
Novartis
»
4 comments
News
Germany's Merck will expand R&D in China
Yahoo/AP
China
Merck KGaA
R&D
»
1 comment
News
Breast Cancer Vaccine Tests German Merck’s $1 Billion Strategy
Bloomberg
breast cancer
Merck KGaA
Stimuvax
vaccines
»
Login
or
register
to post comments
News
King Pharmaceuticals licenses US sales rights for cyanide antidote from Germany-based Merck
Yahoo/AP
Cyanokit
King
liscensing
Merck KGaA
»
1 comment
News
Sanofi, Merck Among Global Bidders for iNova, Review Reports
Bloomberg
Australia
iNova
Merck KGaA
Sanofi
»
112 comments
News
Teva rivals advance on oral MS drug: Merck KGaA and Novartis have completed Phase III trials of their drugs, and are filing for approval
Trading Markets
Merck KGaA
multiple sclerosis
Novartis
Teva Pharmaceuticals
»
Login
or
register
to post comments
News
Conflicting Erbitux Study Data Hurts Merck Shrs
WSJ Online
Erbitux
Merck KGaA
»
2 comments
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT